Refinement of the Hamster Model of Clostridium difficile Disease

  • Gillian Douce
  • David Goulding
Part of the Methods in Molecular Biology™ book series (MIMB, volume 646)

Abstract

The Golden Syrian hamster is widely regarded as the most relevant small animal model of Clostridium difficile disease as oral infection of animals pre-treated with antibiotics reproduces many of the symptoms observed in man. These include diarrhoea, histological damage, colonisation of the large bowel and sporulation of the organism at the terminal stage of the disease. However, infection results in a fatal outcome, which in the past has been used as an experimental endpoint. More recently, attempts have been made to refine the model to maximise the scientific data generated whilst minimising animal suffering. This has been achieved using a combination of qualitative and quantitative measurements taken during the course of the infection and at post-mortem. This has allowed timing of experiments to be optimised to ensure appropriate monitoring of animals during the acute phase of infection and provides opportunities to establish appropriate humane endpoints to these experiments.

Key words

Clostridium difficile Golden Syrian hamster telemetry colonisation histological damage 

References

  1. 1.
    Barbut F, et al. (2007) Clinical features of Clostridium difficile – associated infections and molecular characterisation of strains: results of a restrospective study, 2000–2004. Infect Control Hosp Epidemiol 28, 131–139.PubMedCrossRefGoogle Scholar
  2. 2.
    Spencer RC. (1998) Clinical impact and associated costs of Clostridium difficile associated disease. J Antimicrob Chemother 41, 5–12.PubMedCrossRefGoogle Scholar
  3. 3.
    Bartlett JG, et al. (1977) Clindamycin associated colitis due to a toxin producing species of Clostridium in hamsters. J Infect Dis 136, 701–705.PubMedCrossRefGoogle Scholar
  4. 4.
    Torres JF, et al. (1995) Evaluation of formalin inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunisation in hamsters. Infect Immun 63, 4619–4627.PubMedGoogle Scholar
  5. 5.
    Kim PH and Rolfe RD. (1989) Immunisation of adult hamsters against Clostridium difficile associated ileocecitis and transfer of protection to infant hamsters. Infect Immun 5(5), 2984–2992.Google Scholar
  6. 6.
    Drudy D, et al. (2007) Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect Control Hosp Epidemiol 28,932–940.PubMedCrossRefGoogle Scholar
  7. 7.
    Cerquetti M, et al. (2002) Binding of Clostridium difficile to Caco-2 epithelial cell line and extracellular matrix proteins. FEMS Immunol Med Microbiol 32, 211–218.PubMedCrossRefGoogle Scholar
  8. 8.
    Razaq N, et al. (2007) Infection of hamsters with historic and epidemic BI types of Clostridium difficile. J Infect Dis 196, 1813–1817.PubMedCrossRefGoogle Scholar
  9. 9.
    Sambol SP, et al. (2001) Infection of hamsters with epidemiologically important strains of Clostridium difficile. J Infect Dis 183, 1760–1766.PubMedCrossRefGoogle Scholar
  10. 10.
    Naaber P, et al. (1998) Bacterial translocation, intestinal microflora and morphological changes in experimental models of Clostridium difficile infection. J Med Micro 47,591–598.CrossRefGoogle Scholar
  11. 11.
    Marsh JW, et al. (2006) Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in hospitals. J Clin Microbiol 44, 2558–2566.PubMedCrossRefGoogle Scholar
  12. 12.
    Malik LE and Wilson RB. (1975) Modified thiocarbohydrazide procedure for scanning electron microscopy: routine use for normal, pathological, or experimental tissue. Stain Technology 50, 265–269.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Gillian Douce
    • 1
  • David Goulding
    • 2
  1. 1.Division of Infection and Immunity, IBLS, Glasgow Biomedical Research CentreUniversity of GlasgowGlasgowUK
  2. 2.Wellcome Trust Genome CampusWellcome Trust Sanger InstituteCambridgeUK

Personalised recommendations